Cell therapy developer
Appears in 1 story · Last updated Nov 8, 2026
Subsidiary of Ayrmid; would absorb Karyopharm if the deal closes
Karyopharm Therapeutics filed for Chapter 11 on November 2, 2026, naming Ayrmid Ltd. as the lead bidder for its assets. A bankruptcy judge has approved bidding rules that set a December 16 deadline for competing offers, an auction on December 21 and a sale hearing on January 11, 2027.
Updated 4 days ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
